journal article·2025-12

Oxygen plasma-defect engineered WS2 nanosheets for combination therapy: Folate-targeted, photothermal, and electroporation-enhanced chemotherapy

Mehran Khodayari, Mehrnaz Esfandiari, Mojtaba Kamankesh, Hoda Borooghani, Heshmat Asgharian, Behnaz Esfandiari, Shams Mohajerzadeh

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (67)

Show source-provided references
1. Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance10.1038/s44276-025-00129-2 ↗
2. Multilevel mechanisms of cancer drug resistance10.3390/ijms252212402 ↗
3. Emerging therapeutic strategies to overcome drug resistance in cancer cells10.3390/cancers16132478 ↗
4. Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches10.3389/fonc.2022.891652 ↗
5. Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy10.1016/j.cell.2017.11.009 ↗
6. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives10.1038/s41392-021-00572-w ↗
7. Electrochemotherapy: an alternative strategy for improving therapy in drug-resistant SOLID tumors10.3390/cancers14174341 ↗
8. Electroporation, electrochemotherapy and electro-assisted drug delivery in cancer. A state-of-the-art review10.1016/j.bpc.2022.106819 ↗
9. Is electroporation the key to drug delivery in drug-resistant cancers?, Expert Opin
10. Electroporation in clinical applications—the potential of gene electrotransfer and electrochemotherapy10.3390/app122110821 ↗
11. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation10.1186/s12943-023-01865-0 ↗
12. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
13. Nanoparticle-mediated drug delivery systems for precision targeting in oncology10.3390/ph17060677 ↗
14. Developments in nanotechnology approaches for the treatment of solid tumors10.1186/s40164-025-00656-1 ↗
15. A novel microscale platform for leukemia tumor treating field therapy and electrochemical screening10.1016/j.mee.2022.111738 ↗
16. Tungsten disulfide-based materials and their conjugates for cancer photothermal therapy10.3390/jcs8110460 ↗
17. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy10.1016/j.actbio.2024.03.019 ↗
18. MoS2-based nanocomposites for cancer diagnosis and therapy
19. MoS2-Based nanocomposite for synergistic chemo-photothermal cancer therapy10.1038/s41598-025-05615-8 ↗
20. Facile and scalable synthesis of vertically oriented TiS2 nanosheets for green energy harvesting in microfluidic microbial fuel cells10.1021/acs.energyfuels.4c05967 ↗
21. Unleashing the potential of tungsten disulfide: current trends in biosensing and nanomedicine applications10.1016/j.heliyon.2024.e24427 ↗
22. Magnetic WS2 nanosheets functionalized by biomimetic lipids with enhanced dispersibility for combined photothermal and chemotherapy therapy
23. A laser-assisted electrochemical biosensor based on folic acid-functionalized tungsten disulfide nanosheets for label-free cancer cell detection10.1016/j.snb.2023.133443 ↗
24. Plasma modification techniques for natural polymer-based drug delivery systems10.3390/pharmaceutics15082066 ↗
25. O2 plasma etching and antistatic gun surface modifications for CNT yarn microelectrode improve sensitivity and antifouling properties10.1021/acs.analchem.7b00785 ↗
26. Electro-deformation spectroscopy: a unified method for simultaneous electrical and mechanical characterization of single cells10.1016/j.actbio.2024.12.012 ↗
27. Effects of cell morphology and electrical properties on electric field and dielectrophoretic force generated in cell exposed to tumor-treating field10.1088/1757-899X/1096/1/012003 ↗
28. Edge defects promoted oxidation of monolayer WS2 synthesized on epitaxial graphene10.1021/acs.jpcc.0c00350 ↗
29. Formation of few- and monolayered WS2 sheets using plasma-treated dimethyl-sulfoxide solvent-based exfoliation10.1002/pssr.201900396 ↗
30. Formation of large area WS2 nanosheets using an oxygen-plasma assisted exfoliation suitable for optical devices10.1088/1361-6528/ab31b5 ↗
31. Molecule-induced n-type behavior of phosphorene-based field-effect transistor for highly sensitive detection of sialic acid10.1016/j.electacta.2023.143228 ↗
32. Understanding loading, diffusion and releasing of Doxorubicin and Paclitaxel dual delivery in graphene and graphene oxide carriers as highly efficient drug delivery systems10.1016/j.apsusc.2019.144220 ↗
33. Effective PEGylation method to improve biocompatibility of graphene derivatives10.1016/j.eurpolymj.2020.109504 ↗
34. Influence of PEGylation on WS2 nanosheets and its application in photothermal therapy10.1021/acsabm.3c00506 ↗
35. Lattice dynamics in mono- and few-layer sheets of WS2 and WSe210.1039/c3nr03052k ↗
36. Polyethylene glycol intercalation for MoS2 enables fast zinc-ion storage via pseudocapacitance10.1007/s11581-024-05441-4 ↗
37. Oxygen-doped MoS2 with expanded interlayer spacing for rapid and stable polysulfide conversion
38. Measuring the lateral size of liquid-exfoliated nanosheets with dynamic light scattering10.1088/0957-4484/24/26/265703 ↗
39. Identification of individual and few layers of WS2 using Raman Spectroscopy10.1038/srep01755 ↗
40. Raman fingerprint of interlayer coupling in 2D TMDCs10.3390/nano12223949 ↗
41. Strain engineering and Raman spectroscopy of monolayer transition metal dichalcogenides10.1021/acs.chemmater.8b01672 ↗
42. Surface functionalization of WS2 nanosheets with alkyl chains for enhancement of dispersion stability and tribological properties10.1021/acsami.1c17162 ↗
43. Investigating heterogeneous defects in single-crystalline WS2 via tip-enhanced Raman spectroscopy10.1038/s41699-022-00334-4 ↗
44. Electrostatic and electrosteric stabilization of aqueous suspensions of barite nanoparticles10.1016/j.powtec.2008.12.010 ↗
45. Effect of doxorubicin on the near-infrared optical properties of indocyanine green10.1021/acsomega.1c05500 ↗
46. CVD controlled growth of large-scale WS2 monolayers10.1039/C9RA06219J ↗
47. Single-layer MoS2-based nanoprobes for homogeneous detection of biomolecules10.1021/ja4019572 ↗
48. Strong dependence of fluorescence quenching on the transition metal in layered transition metal dichalcogenide nanoflakes for nucleic acid detection10.1039/C6AN00454G ↗
49. Comparison of MoS2, WS2, and graphene oxide for DNA adsorption and sensing10.1021/acs.langmuir.6b04502 ↗
50. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer10.1002/adma.201305256 ↗
51. A temperature-responsive drug release system based on MoS2 nanosheets and 1-tetradecanol10.1016/j.colsurfa.2023.132061 ↗
52. A multifunctional nanoplatform based on MoS2-nanosheets for targeted drug delivery and chemo-photothermal therapy10.1016/j.colsurfb.2019.110585 ↗
53. Co-delivery of doxorubicin and chloroquine by polyglycerol functionalized MoS2 nanosheets for efficient multidrug-resistant cancer therapy10.1002/mabi.202100233 ↗
54. Electric field distribution and electroporation threshold
55. Histopathological and ultrastructural changes after electroporation in pig liver using parallel-plate electrodes and high-performance generator10.1038/s41598-019-39433-6 ↗
56. Identification of electroporation sites in the complex lipid organization of the plasma membrane10.7554/eLife.74773 ↗
57. Pulsed electric fields can create pores in the voltage sensors of voltage-gated ion channels10.1016/j.bpj.2020.05.030 ↗
58. Calcium electroporation and electrochemotherapy for cancer treatment: importance of cell membrane composition investigated by lipidomics, calorimetry and in vitro efficacy10.1038/s41598-019-41188-z ↗
59. Voltage-gated sodium channels in cancers10.1186/s40364-024-00620-x ↗
60. Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
61. Targeted proteomics enables simultaneous quantification of folate receptor isoforms and potential isoform-based diagnosis in breast cancer
62. Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis10.1039/D3SC05539F ↗
63. Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: a state-of-the-art review10.1002/ddr.21758 ↗
64. Tackling anticancer drug resistance and endosomal escape in aggressive brain tumors using bioelectronics10.1021/acsomega.4c05794 ↗
65. Development of accurate temperature regulation culture system with metallic culture vessel demonstrates different thermal cytotoxicity in cancer and normal cells10.1038/s41598-021-00908-0 ↗
66. Heat stress induces apoptosis through transcription-independent p53-mediated mitochondrial pathways in human umbilical vein endothelial cell10.1038/srep04469 ↗
67. Cell death due to electroporation – a review10.1016/j.bioelechem.2021.107871 ↗